Navigation Links
Plasma in bags
Date:11/11/2011

Physicians are increasingly using live cells in their treatments: in blood transfusions and bone marrow transplants, as well as in stem cell therapies and following severe burns. Cells taken from the patients themselves are ideal for replacing burned skin, eliminating immune deficiencies, repairing degenerated cartilage or to treat injured bones as they are not rejected by the immune system. These cells have to be kept, cultivated, reproduced or even modified in a patient-specific manner. The problem, however, lies in the storability of the cell solutions used. As they can easily become infected by germs, they can only be stored for a few days in the containers conventionally used today. The joint project InnoSurf aims to remedy this problem: scientists from five research institutions, along with partners in the industry have developed innovative plastic surfaces and measuring methods for efficiently producing human cells for diagnostic and therapeutic applications. The work was coordinated by the Helmholz Centre for Infection Research (HZI) in Braunschweig, Germany.

The idea is to cultivate the cells in sealed, sterile plastic bags. The inner surface of the bags has to be modified so that they provide cells with good conditions for survival. A team led by Dr. Michael Thomas at the Fraunhofer Institute for Surface Engineering and Thin Films IST in Braunschweig, Germany, has now developed a plasma technology process for use at atmospheric pressure. "We fill the bags with a specific gas mixture and apply an electrical voltage" explains scientific assistant Dr. Kristina Lachmann. "Inside them, for a brief period, plasma is created, i.e. a luminescent, ionized gas, which chemically alters the plastic surface". During this process the bag remains sterile as plasmas also have a disinfecting action. "The advantage of the process is that it operates at atmospheric pressure and is therefore cost-effective, fast and flexible" emphasizes group leader Dr. Michael
'/>"/>

Contact: Dr. Michael Thomas
michael.thomas@ist.fraunhofer.de
49-531-215-5525
Fraunhofer-Gesellschaft
Source:Eurekalert  

Page: 1 2

Related biology news :

1. RevaTen platelet-rich plasma shows promise as potential treatment for heart attacks
2. MIT researchers study the danger of toxoplasma parasites
3. Scripps Research scientists redefine the role of plasma cells in the immune system
4. Grant advances quark-gluon plasma studies

5. Atmospheric pressure plasma jet from a grounded electrode
6. Toxoplasma gondii spreads in the habitat of the Iberian lynx
7. Modeling Toxoplasma focus of workshop
8. Plasma produces KO cocktail for MRSA
9. How Toxoplasma gondii gets noticed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Plasma in bags
(Date:3/16/2015)... March 16, 2015 Between ... will present groundbreaking innovations in biometric identification at ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... innovation is well at the forefront: the company,s ... made in Germany . BiometricGate ...
(Date:3/12/2015)... The mascots of the Atlantic Coast Conference ... Wake Forest Baptist Medical Center. They stopped by as ... Men,s Basketball Tournament. Young patients enjoyed bonding with their ... autographs. Brenner Children,s Hospital is the pediatric ... children,s hospital in northwest North Carolina ...
(Date:3/12/2015)... , March 12, 2015 WHEN:Tuesday, March 17, ... here: http://bit.ly/1G7Os0L . SPEAKERS: , Frost & ... - http://photos.prnewswire.com/prnh/20150311/181111 Biometric companies ... compete in several different markets and industries. This ... witnessing an uptrend. Join Frost ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... 2013) For nearly half a century, contact lenses ... delivery that may someday replace eye drops, but achieving ... at Massachusetts Eye and Ear/Harvard Medical School Department of ... Technology are one step closer to an eye drop-free ...
... drives the development of tumours in over one per cent ... the gene CUX1 has been broadly linked to cancer development. ... biological pathway is activated that increases tumour growth. Drugs that ... clinic and are in development thus highlighting a potential new ...
... meets the eye following even a mild traumatic brain injury. ... reported in Nature suggest that the brain,s protective ... Using a newly developed mouse trauma model, senior author Dorian ... and Stroke (NINDS), part of the National Institutes of Health, ...
Cached Biology News:Innovative drug-dispensing contact lens delivers glaucoma medication continuously for a month 2Gene promotes 1 in 100 of tumors 2Concussion secrets unveiled in mice and people 2Concussion secrets unveiled in mice and people 3
(Date:3/30/2015)... PMG Research, Benchmark Research, and Miami ... of VaxCorps, a network of highly experienced, geographically ... of vaccine trials in healthy adult, elderly, and ... conducted over 500 phase I-III vaccine clinical trials, ... as well as a vast array of other ...
(Date:3/30/2015)... March 30, 2015 US-Australian drug discovery company, ... subsidiary, CanTx, Inc., and Yale University, on March 27 ... data was presented as an oral presentation by Professor ... School to the 62 nd Annual Scientific Meeting ... San Francisco, CA. In both ...
(Date:3/30/2015)... March 29, 2015 A two-day workshop ... States and plenary talks by four leading photonics researchers ... + Optoelectronics next month in Prague, Czech Republic. ... 17 conferences alongside a two-day exhibition. Sponsored by ... the event will run 13-16 April in the Clarion ...
(Date:3/29/2015)... , March 29, 2015  Caris Life ... in which Caris Molecular Intelligence®, the company,s panomic, ... and differences between several rare and difficult to ... that have the potential to improve patient outcomes. ... B at the Society of Gynecologic Oncology (SGO) ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 2Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 4
... CAMBRIDGE, Mass., Feb. 17 Idenix Pharmaceuticals, Inc. (Nasdaq: ... and development of drugs for the treatment of human viral ... the fourth quarter and year ended December 31, 2008. At ... totaled $46.1 million. Business Highlights , ...
... Relationships Weaken in Many CountriesNEW YORK, Feb. 17 New ... the five major European countries -- the UK, Germany, Spain ... key sales and service activities. Merck takes the top ... UK and Germany. In 2008, Merck and Novartis tied ...
... Inc. (OTC:,SPOM - News), a leading developer of biosensor ... today that it,has appointed Med Tech and Med Care ... US market. , Med Tech ... the healthcare industry and operate with manufacturers,of medical products ...
Cached Biology Technology:Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 2Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 3Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 4Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 5Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 6Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results 7Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US 2Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US 3Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US 4Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US 5Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US 6Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US 7SPO Medical Appoints New US Sales Rep Groups 2SPO Medical Appoints New US Sales Rep Groups 3
No description available in Ensembl. Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Rabbit polyclonal to Yaf9 ( Abpromise for all tested applications)....
... This product is designed to deparaffinize and ... formalin fixed paraffin-embedded tissue sections mounted on ... melting the paraffin at the high temperature ... with emulsification of the paraffin by detergent. ...
... U.S. sourced, ideal for those ... Low hemoglobin; Endotoxin: < 1.0 ... US origin; U.S. sourced, ideal ... uncompromising quality. Low hemoglobin Endotoxin: ...
Biology Products: